China's WuXi To Play Role In U.S. Firm's Expansion Plans
This article was originally published in PharmAsia News
Executive Summary
China's WuXi Pharmatech, in the process of being acquired by Charles River Laboratories International of the United States, is expected to make the American firm a large player in the life-sciences sector